These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20098286)

  • 21. Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort.
    Croome KP; Lee DD; Croome S; Nakhleh RE; Abader Sedki Senada P; Livingston D; Yataco M; Taner CB
    Liver Transpl; 2019 Oct; 25(10):1533-1540. PubMed ID: 31187923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained Virological Response Is Associated with a Decreased Risk of Posttransplant Diabetes Mellitus in Liver Transplant Recipients with Hepatitis C-Related Liver Disease.
    Roccaro GA; Mitrani R; Hwang WT; Forde KA; Reddy KR
    Liver Transpl; 2018 Dec; 24(12):1665-1672. PubMed ID: 30291672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus).
    Van Buren D; Payne J; Geevarghese S; MacDonell R; Chapman W; Wright JK; Helderman JH; Richie R; Pinson CW
    Transplant Proc; 1998 Jun; 30(4):1401-2. PubMed ID: 9636566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weaning of immunosuppression in liver transplant recipients.
    Mazariegos GV; Reyes J; Marino IR; Demetris AJ; Flynn B; Irish W; McMichael J; Fung JJ; Starzl TE
    Transplantation; 1997 Jan; 63(2):243-9. PubMed ID: 9020325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and post-transplant diabetes.
    Humar A; Crotteau S; Gruessner A; Kandaswamy R; Gruessner R; Payne W; Lake J
    Clin Transplant; 2007; 21(4):526-31. PubMed ID: 17645714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and effectiveness of intensive insulin protocol use in post-operative liver transplant recipients.
    Keegan MT; Vrchota JM; Haala PM; Timm JV
    Transplant Proc; 2010 Sep; 42(7):2617-24. PubMed ID: 20832556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of results of combined liver-kidney transplantation vs. isolated liver transplantation.
    Aguilera V; Ferrer I; Berenguer M; Rivera J; Rubín Á; Moya Á; Pareja E; Sánchez J; Prieto M; Mir J
    Ann Hepatol; 2013; 12(2):274-81. PubMed ID: 23396739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term outcomes of paediatric liver transplant recipients after transition to Adult Healthcare Service.
    Ferrarese A; Germani G; Lazzaro S; Cananzi M; Russo FP; Senzolo M; Gambato M; Zanetto A; Cillo U; Gringeri E; Perilongo G; Burra P
    Liver Int; 2018 Jul; 38(7):1316-1321. PubMed ID: 29205755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Degree of Hyperglycemia Excursion in Patients of Kidney Transplantation (KT) or Liver Transplantation (LT) Assessed by Continuous Glucose Monitoring (CGM): Pilot Study.
    Jin HY; Lee KA; Kim YJ; Park TS; Lee S; Park SK; Hwang HP; Yang JD; Ahn SW; Yu HC
    J Diabetes Res; 2019; 2019():1757182. PubMed ID: 31886275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perioperative Glycemic Surveillance and Control-Current Practices, Efficacy and Impact on Postoperative Outcomes following Infrainguinal Vascular Intervention.
    Kinio AE; Gold M; Doonan RJ; Steinmetz O; Mackenzie K; Obrand D; Girsowicz E; Bayne J; Gill HL
    Ann Vasc Surg; 2023 Sep; 95():108-115. PubMed ID: 37003358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.
    Jain A; Kashyap R; Demetris AJ; Eghstesad B; Pokharna R; Fung JJ
    Liver Transpl; 2002 Jan; 8(1):40-6. PubMed ID: 11799484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basiliximab With Delayed Tacrolimus Improves Short-Term Renal Outcomes Post-Liver Transplantation-a Real-World Experience.
    Boyd A; Brown A; Patel J; Nightingale P; Perera MTPR; Ferguson J; Neuberger J; Rajoriya N
    Transplant Proc; 2021 Jun; 53(5):1541-1547. PubMed ID: 34074467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.
    Jain A; Reyes J; Kashyap R; Rohal S; Abu-Elmagd K; Starzl T; Fung J
    Ann Surg; 1999 Sep; 230(3):441-8; discussion 448-9. PubMed ID: 10493490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: Analysis of UNOS Database.
    Simpson N; Cho YW; Cicciarelli JC; Selby RR; Fong TL
    Transplantation; 2006 Nov; 82(10):1298-303. PubMed ID: 17130778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome.
    Rodríguez-Perálvarez M; Germani G; Papastergiou V; Tsochatzis E; Thalassinos E; Luong TV; Rolando N; Dhillon AP; Patch D; O'Beirne J; Thorburn D; Burroughs AK
    J Hepatol; 2013 Feb; 58(2):262-70. PubMed ID: 23023010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression.
    Schwartz JJ; Ishitani MB; Weckwerth J; Morgenstern B; Milliner D; Stegall MD
    Transplantation; 2007 Sep; 84(6):715-21. PubMed ID: 17893604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes?
    Miles AM; Sumrani N; Horowitz R; Homel P; Maursky V; Markell MS; Distant DA; Hong JH; Sommer BG; Friedman EA
    Transplantation; 1998 Feb; 65(3):380-4. PubMed ID: 9484755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver Retransplantation Associated With Kidney Transplantation for End-stage Liver Graft Disease and Renal Insufficiency: A Morbid Procedure on a Unique Subgroup of Patients.
    Cauchy F; Vibert E; Cherqui D; Perdigao F; Sepulveda A; Samuel D; Calmus Y; Conti F; Adam R; Soubrane O; Scatton O
    Transplantation; 2020 Jul; 104(7):1403-1412. PubMed ID: 31651789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-CD25 monoclonal antibody replacement therapy for chronic kidney disease in liver transplant recipients.
    Walsh C; Barkun J; Tchervenkov J; Deschenes M; Ghali P; Wong P; Chaudhury P; Paraskevas S; Metrakos P; Cantarovich M
    Transplantation; 2013 Feb; 95(3):495-500. PubMed ID: 23296149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modifiable Variables Are Major Risk Factors for Posttransplant Diabetes Mellitus in a Time-Dependent Manner in Kidney Transplant: An Observational Cohort Study.
    de Lucena DD; de Sá JR; Medina-Pestana JO; Rangel ÉB
    J Diabetes Res; 2020; 2020():1938703. PubMed ID: 32258163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.